N6-Methyl-dATP: An Epigenetic Nucleotide Analog for Fidelity and Regulatory Studies

Executive Summary:
N6-Methyl-dATP is a methylated deoxyadenosine triphosphate analog with a methyl group at the N6 position of adenine, altering DNA polymerase interactions and fidelity (APExBIO). Its use as a molecular probe enables high-resolution analysis of DNA replication mechanisms and the effects of methylation on genomic stability (3-datp.com). This compound is relevant to acute myeloid leukemia (AML) research, where altered methylation impacts the regulation of transcription factors such as LMO2 and LDB1 (Lu et al., 2023). N6-Methyl-dATP is supplied by APExBIO with ≥90% purity and should be stored at or below -20°C for stability. Its role extends to antiviral drug design through modulation of nucleic acid-enzyme interactions.

Biological Rationale

N6-Methyl-dATP (N6-Methyl-2'-deoxyadenosine-5'-Triphosphate) is a synthetic nucleotide analog where the adenine base is methylated at the N6 position. This structural modification mimics naturally occurring epigenetic DNA methylation but is introduced in a controlled, site-specific fashion. Endogenous N6-methyladenine marks are recognized as epigenetic signals in prokaryotes and some eukaryotes, influencing gene expression, genome stability, and DNA repair. The study of methylated deoxyadenosine triphosphate analogs such as N6-Methyl-dATP allows researchers to directly probe the consequences of methylation on DNA polymerase activity and fidelity, and to model methylation-driven regulatory events in disease contexts such as leukemia (Lu et al., 2023). By substituting N6-Methyl-dATP for canonical dATP in in vitro assays, scientists gain mechanistic insight into the selectivity of DNA polymerases and the functional consequences of methylation on DNA-protein interactions.

Mechanism of Action of N6-Methyl-dATP

N6-Methyl-dATP acts as a substrate analog for DNA polymerases. The methyl group at the N6 position of adenine increases steric hindrance and alters the hydrogen bonding profile of the nucleotide. This can reduce or modify the efficiency of its incorporation into nascent DNA strands, depending on the polymerase type and assay conditions. The presence of N6-methylation can disrupt base pairing fidelity, challenge proofreading functions, and modulate enzyme recognition (n6-methyl.com). In studies of epigenetic regulation, N6-Methyl-dATP provides a precise molecular tool to test how methylation affects the activity of DNA-modifying enzymes, nucleases, and transcription factors. Its use in in vitro and cell-based systems enables direct observation of methylation-driven changes in genomic stability and gene regulation pathways, particularly in disease models such as AML where aberrant methylation is implicated in transcription factor dysregulation.

Evidence & Benchmarks

• N6-Methyl-dATP incorporation into DNA by high-fidelity polymerases is markedly reduced compared to dATP at 37°C in Tris-HCl pH 7.5 buffer, indicating selective polymerase exclusion (3-datp.com).
• Methylation at the N6 position of adenine disrupts canonical hydrogen bonding, decreasing DNA duplex stability by 1.2–1.5 °C per modification under standard salt conditions (0.1 M NaCl) (iodoacetyl-lc-biotin.com).
• In AML models, altered methylation patterns at adenine bases are associated with changes in the expression of transcriptional regulators such as LMO2 and LDB1, which mediate leukemogenesis and affect cell survival (Lu et al., 2023).
• APExBIO's N6-Methyl-dATP (SKU: B8093) is purified to ≥90% by anion exchange HPLC and is stable at -20°C for short-term storage (APExBIO).
• N6-Methyl-dATP enables competitive inhibition assays to dissect DNA polymerase substrate selectivity, facilitating quantitative analysis of methylation effects on enzymatic kinetics (n6-methyl.com).

Applications, Limits & Misconceptions

Applications:

• DNA Replication Fidelity Studies: Used as a probe to evaluate polymerase discrimination and error rates in the presence of methylated nucleotides (3-datp.com).
• Epigenetic Regulation Pathway Research: Models the impact of methylation on gene expression regulation, particularly in cancer biology and antiviral research.
• Antiviral Drug Design: Serves as a template for developing nucleoside analog inhibitors targeting viral polymerases that are sensitive to methylation modifications.
• Genomic Stability Analysis: Provides experimental control to assess the consequences of site-specific methylation on DNA repair and chromatin architecture.

This article extends the mechanistic insight from 'N6-Methyl-dATP: Mechanistic Insight and Strategic Guidance' by providing new benchmarks for polymerase selectivity and updates recent findings in AML pathogenesis.

Common Pitfalls or Misconceptions

• N6-Methyl-dATP is not a universal substitute for dATP; many DNA polymerases exhibit reduced or no incorporation, depending on the enzyme and buffer conditions.
• Long-term storage of N6-Methyl-dATP solutions (>1 week) at 4°C leads to degradation; always store at -20°C or below.
• N6-Methyl-dATP does not model cytosine or guanine methylation; it is specific to adenine methylation and cannot be used to probe 5-methylcytosine pathways.
• Interpretation of methylation effects in cellular models requires controls; off-target effects or cellular metabolism of analogs may confound results.
• It is not suitable for direct in vivo therapeutic use; its application is currently limited to in vitro and ex vivo research workflows.

Workflow Integration & Parameters

N6-Methyl-dATP (B8093) from APExBIO is supplied as a solution with a molecular weight of 505.2 (free acid) and chemical formula C₁₁H₁₈N₅O₁₂P₃. For DNA polymerase assays, typical final concentrations range from 10 to 100 µM in buffer (e.g., 10 mM Tris-HCl pH 7.5, 50 mM KCl, 1.5 mM MgCl₂). Always include parallel reactions with canonical dATP for comparison. Store all solutions at -20°C and avoid repeated freeze-thaw cycles. Purity is verified by anion exchange HPLC (≥90%). For methylation modification research, pair with methylation-sensitive restriction enzymes or bisulfite sequencing to confirm incorporation. For AML pathway studies, use in conjunction with gene expression profiling and ChIP-Seq for LMO2/LDB1 targets (Lu et al., 2023).

This article clarifies and extends the practical workflow recommendations from 'N6-Methyl-dATP: Unlocking Epigenetic Mechanisms and Strategic Applications' by providing precise storage, concentration, and control guidelines for replication fidelity and leukemia research.

Conclusion & Outlook

N6-Methyl-dATP is a robust and validated molecular probe for dissecting the mechanistic roles of methylation in DNA replication and epigenetic regulation. Its specific utility in leukemia pathway research is supported by evidence linking methylation changes to transcription factor regulation and genomic instability (Lu et al., 2023). As research advances, N6-Methyl-dATP will likely become increasingly central to precision epigenetics and antiviral strategy development. For high-purity, research-grade N6-Methyl-dATP, refer to APExBIO's B8093 product page. For further mechanistic and application insight, see 'N6-Methyl-dATP: Elevating DNA Replication Fidelity & Epigenetic Research', which focuses on advanced workflows and strategic integration in oncology and antiviral research.